MedPath

Randomised controlled trial comparing the spinal sensory level achieved, duration of action and safety of generic (Bupivacaine 0.5% with Dextrose-PharmaQ) versus original bupivacaine (Macaine 0.5% with dextrose-Adcock Ingram) in spinal anaesthesia

Not Applicable
Not yet recruiting
Conditions
Anaesthesia
Registration Number
PACTR201807735986564
Lead Sponsor
Pireshin Ramdharee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
72
Inclusion Criteria

Male patients
18 - 50 years old
Healthy patients - American Society of Anaesthesiologists physical status grade one and two

Exclusion Criteria

Contraindication to spinal anaesthesia
Local anaesthetic allergy
Patient refusal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.